PubMed=13804596
Brockman R.W.
A mechanism of resistance to 6-mercaptopurine: metabolism of hypoxanthine and 6-mercaptopurine by sensitive and resistant neoplasms.
Cancer Res. 20:643-653(1960)

PubMed=18630317; DOI=10.1093/jnci/36.3.405
Moore G.E., Sandberg A.A., Ulrich K.
Suspension cell culture and in vivo and in vitro chromosome constitution of mouse leukemia L1210.
J. Natl. Cancer Inst. 36:405-421(1966)

PubMed=6970130; DOI=10.1002/eji.1830101111
Conzelmann A., Pink J.R.L., Acuto O., Mach J.-P., Dolivo S., Nabholz M.
Presence of T 145 on cytolytic T cell lines and their lectin-resistant mutants.
Eur. J. Immunol. 10:860-868(1980)

PubMed=6182115; DOI=10.1002/ijc.2910300317
Momparler R.L., Momparler L.F., Samson J.
Combinational chemotherapy of L1210 and L1210/ARA-C leukemia with 5-AZA-2'-deoxycytidine and beta-2'-deoxythioguanosine.
Int. J. Cancer 30:361-364(1982)

PubMed=6890814; DOI=10.1016/0006-2952(82)90096-x
Strobel-Stevens J.D., El Dareer S.M., Trader M.W., Hill D.L.
Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexate.
Biochem. Pharmacol. 31:3133-3137(1982)

PubMed=25277546; DOI=10.1186/1471-2164-15-847; PMCID=PMC4198738
Didion J.P., Buus R.J., Naghashfar Z., Threadgill D.W., Morse H.C. 3rd, Pardo-Manuel de Villena F.
SNP array profiling of mouse cell lines identifies their strains of origin and reveals cross-contamination and widespread aneuploidy.
BMC Genomics 15:847.1-847.11(2014)

PubMed=31220119; DOI=10.1371/journal.pone.0218412; PMCID=PMC6586308
Almeida J.L., Dakic A., Kindig K., Kone M., Letham D.L.D., Langdon S., Peat R., Holding-Pillai J., Hall E.M., Ladd M., Shaffer M.D., Berg H., Li J.-L., Wigger G., Lund S., Steffen C.R., Fransway B.B., Geraghty B., Natoli M., Bauer B.A., Gollin S.M., Lewis D.W., Reid Y.A.
Interlaboratory study to validate a STR profiling method for intraspecies identification of mouse cell lines.
PLoS ONE 14:E0218412-E0218412(2019)